Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $47.5 million.

  • Tandem Diabetes Care's Accounts Payables fell 261.11% to $47.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.5 million, marking a year-over-year decrease of 261.11%. This contributed to the annual value of $44.7 million for FY2024, which is 979.31% down from last year.
  • Latest data reveals that Tandem Diabetes Care reported Accounts Payables of $47.5 million as of Q3 2025, which was down 261.11% from $55.8 million recorded in Q2 2025.
  • Over the past 5 years, Tandem Diabetes Care's Accounts Payables peaked at $61.5 million during Q3 2022, and registered a low of $27.0 million during Q3 2021.
  • Over the past 5 years, Tandem Diabetes Care's median Accounts Payables value was $48.1 million (recorded in 2024), while the average stood at $46.6 million.
  • Per our database at Business Quant, Tandem Diabetes Care's Accounts Payables skyrocketed by 12812.07% in 2022 and then tumbled by 2501.02% in 2023.
  • Over the past 5 years, Tandem Diabetes Care's Accounts Payables (Quarter) stood at $28.0 million in 2021, then surged by 98.81% to $55.7 million in 2022, then fell by 11.02% to $49.6 million in 2023, then dropped by 9.79% to $44.7 million in 2024, then rose by 6.15% to $47.5 million in 2025.
  • Its Accounts Payables was $47.5 million in Q3 2025, compared to $55.8 million in Q2 2025 and $59.8 million in Q1 2025.